Literature DB >> 16099683

Estimating and comparing diagnostic tests' accuracy when the gold standard is not binary.

Nancy A Obuchowski1.   

Abstract

RATIONALE AND
OBJECTIVES: Investigators often need to assess the accuracies of diagnostic tests when the gold standard is not binary-scale. The objective of this article is to describe nonparametric estimators of diagnostic test accuracy when the gold standard is continuous, ordinal, and nominal scale.
MATERIALS AND METHODS: A nonparametric method of estimating and comparing the area under receiver operating characteristic (ROC) curves, proposed by DeLong et al, is extended to situations in which the gold standard is not binary. Two examples illustrate the methods.
RESULTS: Measures of diagnostic test accuracy, their variance, and tests for comparing two diagnostic tests' accuracies in paired designs are presented for situations in which the gold standard is continuous, ordinal, and nominal scale. These summary measures of diagnostic test accuracy are analogous in form and interpretation to the area under the ROC curve.
CONCLUSION: Dichotomizing the outcomes of a gold standard so that traditional ROC methods can be applied can lead to bias. The methods described here are useful for assessing and comparing summary test accuracy when the gold standard is not binary scale. They have limitations similar to other summary indices.

Mesh:

Year:  2005        PMID: 16099683     DOI: 10.1016/j.acra.2005.05.013

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  25 in total

Review 1.  Critical comparison of elastography methods to assess chronic liver disease.

Authors:  Mireen Friedrich-Rust; Thierry Poynard; Laurent Castera
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

2.  Predicting biological impairment from habitat assessments.

Authors:  Jason C Doll
Journal:  Environ Monit Assess       Date:  2011-02-02       Impact factor: 2.513

3.  Assessing the discriminative ability of risk models for more than two outcome categories.

Authors:  Ben Van Calster; Yvonne Vergouwe; Caspar W N Looman; Vanya Van Belle; Dirk Timmerman; Ewout W Steyerberg
Journal:  Eur J Epidemiol       Date:  2012-10-07       Impact factor: 8.082

4.  Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography.

Authors:  Donghee Kim; W Ray Kim; Jayant A Talwalkar; Hwa Jung Kim; Richard L Ehman
Journal:  Radiology       Date:  2013-04-05       Impact factor: 11.105

5.  Accuracy of computed tomography for selecting the revascularization method based on SYNTAX score II.

Authors:  Si Eun Lee; Kyunghwa Han; Jin Hur; Young Jin Kim; Hye-Jeong Lee; Yoo Jin Hong; Dong Jin Im; Byoung Wook Choi
Journal:  Eur Radiol       Date:  2017-12-08       Impact factor: 5.315

6.  Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

Authors:  Joseph Pidala; Brenda Kurland; Xiaoyu Chai; Navneet Majhail; Daniel J Weisdorf; Steven Pavletic; Corey Cutler; David Jacobsohn; Jeanne Palmer; Sally Arai; Madan Jagasia; Stephanie J Lee
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

7.  Point shear wave elastography method for assessing liver stiffness.

Authors:  Giovanna Ferraioli; Carmine Tinelli; Raffaella Lissandrin; Mabel Zicchetti; Barbara Dal Bello; Gaetano Filice; Carlo Filice
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

8.  Reliable and computationally efficient maximum-likelihood estimation of "proper" binormal ROC curves.

Authors:  Lorenzo L Pesce; Charles E Metz
Journal:  Acad Radiol       Date:  2007-07       Impact factor: 3.173

9.  Estimation of an accuracy index of a diagnostic biomarker when the reference biomarker is continuous and measured with error.

Authors:  Mixia Wu; Dianchen Zhang; Aiyi Liu
Journal:  J Biopharm Stat       Date:  2016-08-22       Impact factor: 1.051

10.  Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection.

Authors:  Samer S El-Kamary; Mona M Mohamed; Maissa El-Raziky; Michelle D Shardell; Olfat G Shaker; Wafaa A ElAkel; Gamal Esmat
Journal:  Liver Int       Date:  2013-03-20       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.